« Flipping the Bird | Main | The Cost of International Drug Piracy In California »
August 21, 2006
Data, Data, Whose Got the Data -- & Why?
by Peter Pitts
While I agree that physician-prescribing data shouldn’t be available for marketing purposes minus individual physician consent, there are important public health reasons why this data must continue to be shared with pharmaceutical companies.
When FDA-directed safety warnings are issued, they’re communicated via “Dear Doctor” letters to physicians who have prescribed the drug. This is accomplished quickly and precisely because industry has access to physician-specific prescribing data. And when safety issues arise, that same data helps define the scope of the problem (i.e., how many patients are taking the drug and for how long). Also, FDA-mandated risk management plans, developed for physicians who prescribe higher-risk therapies are targeted through the use of this same prescribing data. It’s also an important tool in clinical trial recruitment, allowing focused efforts towards doctors treating targeted patient populations.
Posted by Peter Pitts at August 21, 2006 08:37 AM
Trackback Pings
TrackBack URL for this entry:
/cgi-bin/mt-tb.cgi/15
